96 related articles for article (PubMed ID: 2929400)
1. The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models.
O'Connor KM; Friehling TD; Kowey PR
Am Heart J; 1989 Apr; 117(4):848-53. PubMed ID: 2929400
[TBL] [Abstract][Full Text] [Related]
2. Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
O'Connor KM; Friehling TD; Kelliher GJ; MacNab MW; Wetstein L; Kowey PR
Am Heart J; 1986 Apr; 111(4):683-8. PubMed ID: 3953390
[TBL] [Abstract][Full Text] [Related]
3. The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models.
Luketich J; Friehling TD; O'Connor KM; Kowey PR
Am Heart J; 1989 Aug; 118(2):265-71. PubMed ID: 2750648
[TBL] [Abstract][Full Text] [Related]
4. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.
Kitzen JM; Lynch JJ; Uprichard AC; Venkatesh N; Lucchesi BR
Pharmacology; 1988; 37(3):171-86. PubMed ID: 3227051
[TBL] [Abstract][Full Text] [Related]
5. Influence of site of stimulation on measurement of ventricular vulnerability in the normal and ischemic feline heart.
Kowey PR; Friehling TD; Wetstein L; O'Connor KM; Kelliher GJ
Am J Cardiol; 1984 Aug; 54(3):421-3. PubMed ID: 6465027
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
Imamoto T; Terashita Z; Tanabe M; Nishikawa K; Hirata M
J Cardiovasc Pharmacol; 1986; 8(4):832-9. PubMed ID: 2427826
[TBL] [Abstract][Full Text] [Related]
7. Ventricular tachyarrhythmias in rats with acute myocardial infarction involves activation of small-conductance Ca2+-activated K+ channels.
Gui L; Bao Z; Jia Y; Qin X; Cheng ZJ; Zhu J; Chen QH
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H118-30. PubMed ID: 23086994
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined thromboxane synthetase inhibition/thromboxane receptor antagonism in two models of sudden cardiac death in the canine: limited role for thromboxane.
Kitzen JM; Chi LG; Uprichard AC; Lucchesi BR
J Cardiovasc Pharmacol; 1990 Jul; 16(1):68-80. PubMed ID: 1696668
[TBL] [Abstract][Full Text] [Related]
9. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion.
Austin JC; Berrizbeitia LD; Schoen FJ; Kauffman RP; Hechtman HB; Cohn LH
Am Heart J; 1988 Mar; 115(3):505-9. PubMed ID: 3344655
[TBL] [Abstract][Full Text] [Related]
11. High-current stimuli to the spared epicardium of a large infarct induce ventricular tachycardia.
Kavanagh KM; Kabas JS; Rollins DL; Melnick SB; Smith WM; Ideker RE
Circulation; 1992 Feb; 85(2):680-98. PubMed ID: 1735161
[TBL] [Abstract][Full Text] [Related]
12. A model of chronic ischemic arrhythmias: the relation between electrically inducible ventricular tachycardia, ventricular fibrillation threshold and myocardial infarct size.
Gang ES; Bigger JT; Livelli FD
Am J Cardiol; 1982 Sep; 50(3):469-77. PubMed ID: 7113930
[TBL] [Abstract][Full Text] [Related]
13. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
[TBL] [Abstract][Full Text] [Related]
14. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death.
Hammon JW; Oates JA
Circulation; 1986 Feb; 73(2):224-6. PubMed ID: 3510761
[TBL] [Abstract][Full Text] [Related]
15. Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
Coker SJ
J Mol Cell Cardiol; 1984 Jul; 16(7):633-41. PubMed ID: 6433026
[TBL] [Abstract][Full Text] [Related]
16. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
Linz D; Wirth K; Ukena C; Mahfoud F; Pöss J; Linz B; Böhm M; Neuberger HR
Heart Rhythm; 2013 Oct; 10(10):1525-30. PubMed ID: 23851058
[TBL] [Abstract][Full Text] [Related]
17. HBI-3000 prevents secondary sudden cardiac death.
Lee JY; Lucchesi BR
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
[TBL] [Abstract][Full Text] [Related]
18. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
[TBL] [Abstract][Full Text] [Related]
19. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia.
Na HS; Kim YI; Yoon YW; Han HC; Nahm SH; Hong SK
Am Heart J; 1996 Jul; 132(1 Pt 1):78-83. PubMed ID: 8701879
[TBL] [Abstract][Full Text] [Related]
20. Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat.
Cooper DR; Kelliher GJ; Kowey PR
Am Heart J; 1988 Nov; 116(5 Pt 1):1194-200. PubMed ID: 3142241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
